PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x; PMCID=PMC5926714
Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M., Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K., Yasumoto K.
Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
Jpn. J. Cancer Res. 92:309-315(2001)

PubMed=12114371; DOI=10.1378/chest.122.1.282
Sugaya M., Takenoyama M., Osaki T., Yasuda M., Nagashima A., Sugio K., Yasumoto K.
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy.
Chest 122:282-288(2002)

PubMed=15994973; DOI=10.1158/0008-5472.CAN-04-3787
So T., Takenoyama M., Mizukami M., Ichiki Y., Sugaya M., Hanagiri T., Sugio K., Yasumoto K.
Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.
Cancer Res. 65:5945-5952(2005)

PubMed=16651449; DOI=10.1158/0008-5472.CAN-05-3840
Fukuyama T., Hanagiri T., Takenoyama M., Ichiki Y., Mizukami M., So T., Sugaya M., So T., Sugio K., Yasumoto K.
Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
Cancer Res. 66:4922-4928(2006)

PubMed=17131342; DOI=10.1002/ijc.22396
Sugaya M., Takenoyama M., Shigematsu Y., Baba T., Fukuyama T., Nagata Y., Mizukami M., So T., Ichiki Y., Yasuda M., So T., Hanagiri T., Sugio K., Yasumoto K.
Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lung.
Int. J. Cancer 120:1055-1062(2007)

PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x; PMCID=PMC11159702
Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K.
Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.
Cancer Sci. 98:1048-1054(2007)

PubMed=17725806; DOI=10.1111/j.1349-7006.2007.00586.x; PMCID=PMC11159108
Baba T., Hanagiri T., Ichiki Y., Kuroda K., Shigematsu Y., Mizukami M., Sugaya M., Takenoyama M., Sugio K., Yasumoto K.
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Cancer Sci. 98:1795-1802(2007)

PubMed=19799608; DOI=10.1111/j.1349-7006.2009.01351.x; PMCID=PMC11159900
Kuroda K., Takenoyama M., Baba T., Shigematsu Y., Shiota H., Ichiki Y., Yasuda M., Uramoto H., Hanagiri T., Yasumoto K.
Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma.
Cancer Sci. 101:46-53(2010)

PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210
Kasai F., Fukushima M., Miyagi Y., Nakamura Y.
Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan.
Hum. Cell 37:944-950(2024)